Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pragmatic trial to assess the possibility of enhancing the effectiveness of tinnitus retraining therapy (TRT) by concomitant treatment with Ginkgo biloba extract EGb 761 in patients with chronic tinnitus

Next Previous
Trial Profile

Pragmatic trial to assess the possibility of enhancing the effectiveness of tinnitus retraining therapy (TRT) by concomitant treatment with Ginkgo biloba extract EGb 761 in patients with chronic tinnitus

Status: Discontinued
Phase of Trial: Phase II

Latest Information Update: 14 Jun 2017

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs EGb 761 (Primary)
  • Indications Tinnitus
  • Focus Therapeutic Use
  • Sponsors Dr. Willmar Schwabe Pharmaceuticals

Most Recent Events

  • 09 Jun 2017 Status changed from completed to discontinued.
  • 01 Jul 2016 Status changed from recruiting to completed.
  • 10 Jun 2014 Status changed from not yet recruiting to recruiting, according to ISRCTN: Current Controlled Trials record.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top